Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2008
10/15/2008CN101284755A Chemical synthesis process for conjugated alkenes compounds
10/14/2008US7435824 Prodrugs of potassium channel inhibitors
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008US7435822 Delta and mu opioid receptors modulators, agonist or antagonist; analgesics, immunosuppressants, antiinflammatory agents; 3-(Phenyl-thiophen-3-yl-methylene)-8-aza-bicyclo[3.2.1]octane; ; neurological and psychiatric conditions; drug and alcohol abuse,; gastritis; diarrhea; cardiovascular; respiratory
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435736 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2222138C Method of preparing 3-haloalkyl-1h-pyrazoles
10/09/2008WO2008121877A2 Cftr inhibitor compounds and uses thereof
10/09/2008WO2008121861A2 Pyrazole and pyrrole compounds useful in treating iron disorders
10/09/2008WO2008121817A2 Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition
10/09/2008WO2008121669A1 4-bromo-3-methyl-5-propoxythiophene-2-carboxylic acid 2,5-dioxo-pyrrolidin-1-yl ester, its regio-specific synthesis and intermediate thereto
10/09/2008WO2008121666A1 Use of 4-bromo-3-methyl-5-propoxythiophene-2-carboxylic acid 2,5-dioxo-pyrrolidin-1-yl ester for preparing the tryptase inhibitor [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone
10/09/2008WO2008121592A2 Acetyl coenzyme a carboxylase inhibitors
10/09/2008WO2008120810A1 Compound, photoelectric converter and photoelectrochemical cell
10/09/2008WO2008120759A1 Urea compound and use thereof
10/09/2008WO2008120744A1 Five-membered cyclic amide compound and use thereof
10/09/2008WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same
10/09/2008WO2008120661A1 Novel fused pyrrole derivative
10/09/2008WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof
10/09/2008WO2008119694A1 Benzimidazole cannabinoid agonists
10/09/2008WO2008119689A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/09/2008WO2008101682A3 Iminipyridine derivatives and their uses as microbiocides
10/09/2008WO2008094912A3 Substituted gamma lactams as therapeutic agents
10/09/2008WO2008086188A3 Thiophene carboxamides as factor xa inhibitors
10/09/2008WO2008070354A3 5- and 6- substituted benzimidazole thiophene compounds
10/09/2008WO2008057873A3 Inhibitors of hepatitis c virus
10/09/2008WO2008057871A3 Inhibitors of hepatitis c virus
10/09/2008WO2007149478A3 Pyrazine derivatives with extended conjugation and uses thereof
10/09/2008US20080249302 neuronal nitric oxide synthase (nNOS) isoform inhibitors; 2-ethyl-1-(1H-indol-5-yl)-isothiourea; neurogenerative disorders, stroke, reperfusion injury, head trauma, migraine headache, neuropathic pain, drug abuse, hyperalgesia
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
10/09/2008US20080249150 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
10/09/2008US20080249128 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
10/09/2008US20080249111 Piperdine Derivatives as CCR5 Inhibitors
10/09/2008US20080249110 Novel Substituted 3-Sulfur Indoles
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
10/09/2008CA2681757A1 Methods and compositions for selectin inhibition
10/09/2008CA2681733A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/08/2008EP1978023A1 Pyridazines as fungicides
10/08/2008EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1976833A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976829A2 N-(6-membered aromatic ring)-amido anti-viral compounds
10/08/2008EP1976511A2 Fluorinated arylamide derivatives
10/08/2008EP1976385A2 Anthranilamide derivatives and their use for the control of insects and acari
10/08/2008EP1881830B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
10/08/2008EP1778680B1 Spirocyclic cyclohexane derivatives
10/08/2008EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/08/2008EP1478628B1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
10/08/2008EP1335902B1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
10/08/2008CN101282972A Piperidine and piperazine derivatives as P2X3 antagonists
10/08/2008CN101282948A Phosphatidylinositol 3-kinase inhibitors and methods of their use
10/08/2008CN101282931A Tanaka Hiroaki
10/08/2008CN101282928A Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
10/08/2008CN100424079C Bis-sulfonamides
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432392 Ester derivatives and medical use thereof
10/07/2008US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432286 Pharmaceutically active sulfonyl hydrazide derivatives
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/07/2008US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
10/07/2008US7432273 cancer and/or viral infection, leukemia; improved pharmacological properties; oral bioavailability, greater potency, extended half-life in vivo, Side effects reduction; 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-6-diethoxy-phosphoryl)-hexanoic acid, diethyl cyano phosphonate
10/07/2008US7432271 Atherosclerosis; anticholesterol agents; cardiovascular disorders; stroke; thrombosis; hypotensive agents; restenosis; antidiabetic agents; antiarthritic agents; anticancer agnets; inflammatory bowel disorders
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
10/07/2008CA2433772C Pyrimidine matrix metalloproteinase inhibitors
10/07/2008CA2426009C Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008116620A1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/02/2008WO2008116308A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity
10/02/2008WO2008099076A3 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
10/02/2008WO2008080891A3 Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
10/02/2008WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors
10/02/2008US20080242701 Antitumor agents; anticancer agents; cytotoxic activity; angiogenesis inhibitor; leukemia; colorectal cancer; administering by mouth
10/02/2008US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
10/02/2008US20080242664 Dna-pk inhibitors
10/02/2008US20080242658 Inhibitors of Iap
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008US20080241943 Fluorescent dye-doped crystalline assay; high throughput
10/02/2008US20080241742 Photoresists; using compound containing an orgaooxygen or organosulfur compound
10/02/2008CA2681821A1 Indole carboxamides as ikk2 inhibitors
10/02/2008CA2681771A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity
10/02/2008CA2681431A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of .beta.-secretase
10/02/2008CA2681206A1 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/01/2008EP1975142A1 Automated solid phase synthesis of pyrrole-imidazole polyamide
10/01/2008EP1974608A1 Arylpyridazines as fungicides
10/01/2008EP1973918A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/01/2008EP1805163B1 1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalenes: tricyclic thiophene derivatives as s1p1/edg1 receptor agonists
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008CN101277951A 2-aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
10/01/2008CN101277946A Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 523